OUR FRAGMENT PRODUCTS
Please visit zenobiafragments.com to learn more about our products to support your screening needs. Our products are used in our internal CNS discovery research programs and have yielded hits for a diverse array of targets around the world. We also offer a collection of support services to compliment our products.
Full collection of 967 highly core diverse fragments that meet our internal Guideline of Two
FRADDITIVES FOR CRYSTALLIZATION
Unique fragment-based reagents for protein solubilization and crystallization
ALL ABOUT US
Zenobia Therapeutics was founded in 2008 with a focus on discovering treatments for neurodegenerative diseases using fragment-based lead discovery. In 2014, Zenobia added a products division, Zenobia Fragments that supplies products and services to support fragment-based lead discovery.